Evidence map›Paper›PMID 34366834›Full record

ArticleFrontiers in pharmacology2021

Paula Ferreira Salles, Daiana Souza Perce-da-Silva, Atila Duque Rossi, Luisa Riehl Raposo, Aina Danaisa Ramirez Ramirez, Otílio Machado Pereira Bastos, Lilian Rose Pratt-Riccio, Gustavo Capatti Cassiano, Andrea Regina Souza Baptista, Cynthia Chester Cardoso and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Paula Ferreira SallesCentro de Investigação de Microrganismos, Universidade Federal Fluminense, Niterói, Brazil.
Daiana Souza Perce-da-SilvaFaculdade de Medicina de Petrópolis, Petrópolis, Brazil.
Atila Duque RossiLaboratório de Virologia Molecular, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Luisa Riehl RaposoLaboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Aina Danaisa Ramirez RamirezCentro de Investigação de Microrganismos, Universidade Federal Fluminense, Niterói, Brazil.
Otílio Machado Pereira BastosCentro de Investigação de Microrganismos, Universidade Federal Fluminense, Niterói, Brazil.
Lilian Rose Pratt-RiccioLaboratório de Malária, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Gustavo Capatti CassianoSaúde Global e Medicina Tropical, Instituto de Higiene e Medicina Tropical, Universidade de Lisboa, Lisbon, Portugal.
Andrea Regina Souza BaptistaCentro de Investigação de Microrganismos, Universidade Federal Fluminense, Niterói, Brazil.
Cynthia Chester CardosoLaboratório de Virologia Molecular, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Dalma Maria BanicLaboratório de Imunologia Clínica, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Ricardo Luiz Dantas MachadoCentro de Investigação de Microrganismos, Universidade Federal Fluminense, Niterói, Brazil.
Universidade Federal Fluminense · BRFundação Oswaldo Cruz · BRUniversidade Federal do Rio de Janeiro · BRFaculdade de Medicina de Petrópolis · BRInstituto de Medicina Tropical · PY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic variability was linked with individual responses to treatment and susceptibility to malaria by

Indexed as

CYP2D6Genetic polymorphismpharmacogeneticsPlasmodium vivaxprimaquinerelapses

Identifiers

PMID34366834
PMCPMC8343396
OpenAlexW3184028994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.